-
Gilead Sciences Inc. (GILD $138.80)
-
AbbVie Inc. (ABBV $206.37)
-
Bristol-Myers Squibb Company (BMY $57.67)
-
Pfizer Inc. (PFE $27.10)
-
iShares U.S. Medical Devices ETF (IHI $53.19)
Q: Your thoughts on keeping three out of 5 pharma names: ETF IHI, Gilead Sciences, Bristol Meyers, Abbvie and just bought Pfeizer few weeks ago - hopeful on the Seagen purchase in 2023. I have room only for 3,
Thank you!
Thank you!